Pfizer says once-a-month weight-loss drug works as it forecasts profit decline
Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the Trump administration’s policies on…
Statuses
Credo: I Am Not Doing The Same Mistake Again (Upgrade)
View Source Most popular articles February 3, 2026 5:08 am
How a single tech heavyweight managed to pull the rug on gold and global markets
Panmure Liberum’s Joachim Klement says last week’s Microsoft jolt triggered a contagion effect across trendy assets. View Source Barbara Kollmeyer MarketWatch.com – Top Stories February…
Merck’s outlook for 2026 comes in lower-than-expected as pipeline faces make-or-break year
Merck’s stock falls as the full-year revenue and profit outlooks were below expectations. View Source Jaimy Lee MarketWatch.com – Top Stories February 3, 2026 4:55…
Wall Street Breakfast Podcast: Palantir Powers Past Expectations
View Source Most popular articles February 3, 2026 4:40 am
Gold and silver rally, after 13% fall over two sessions for yellow metal
Gold and silver rose for the first time in two sessions on Tuesday after last week’s record-setting shakeout. View Source Steve Goldstein MarketWatch.com – Top…
Gold, Silver And Equities Evidence Positive Vol/Spot Correlation
View Source Most popular articles February 3, 2026 3:19 am
‘I’m spooked’: Do gold and silver belong in my retirement portfolio after their dramatic fall in value?
“Before you ask, there is nothing extreme about 5% of my ‘alternative’ assets.” View Source Quentin Fottrell MarketWatch.com – Top Stories February 3, 2026 3:15…
During the worst day for gold in 46 years, options traders made bets the metal could hit $20,000
During Friday’s gold price meltdown, open interest in options on gold rose significantly with traders placing large wagers on the gold price doubling, tripling and…